statistiche ricercatore

Continente	#
NA - Nord America	495
AS - Asia	364
EU - Europa	214
SA - Sud America	79
AF - Africa	18
Continente sconosciuto - Info sul continente non disponibili	14
Totale	1.184

Nazione	#
US - Stati Uniti d'America	477
CN - Cina	192
IE - Irlanda	75
SG - Singapore	62
BR - Brasile	57
HK - Hong Kong	36
RU - Federazione Russa	33
FI - Finlandia	31
VN - Vietnam	30
IT - Italia	17
DE - Germania	15
FR - Francia	14
ZA - Sudafrica	14
BD - Bangladesh	11
CA - Canada	7
IN - India	7
EC - Ecuador	6
UA - Ucraina	6
VE - Venezuela	6
AR - Argentina	5
GB - Regno Unito	5
ID - Indonesia	4
MX - Messico	4
SE - Svezia	4
IQ - Iraq	3
PH - Filippine	3
PL - Polonia	3
UZ - Uzbekistan	3
BG - Bulgaria	2
CL - Cile	2
CO - Colombia	2
ES - Italia	2
JP - Giappone	2
NL - Olanda	2
SA - Arabia Saudita	2
TT - Trinidad e Tobago	2
AT - Austria	1
AZ - Azerbaigian	1
BH - Bahrain	1
BO - Bolivia	1
BY - Bielorussia	1
CW - ???statistics.table.value.countryCode.CW???	1
DO - Repubblica Dominicana	1
GA - Gabon	1
GP - Guadalupe	1
HN - Honduras	1
IL - Israele	1
IR - Iran	1
KE - Kenya	1
KR - Corea	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
NI - Nicaragua	1
NP - Nepal	1
QA - Qatar	1
RS - Serbia	1
SV - El Salvador	1
TN - Tunisia	1
TR - Turchia	1
YE - Yemen	1
Totale	1.171

Nome	#
Is the Mg(2+)-ATP-dependent proton pumping activity of the synaptic vesicles a factor involved in the cerebral hypoxia?	139
Affective disorders, antidepressant drugs and brain metabolism	124
Effect of hypoxia and pharmacological treatment on some enzyme activities in dog brain areas	120
Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment	106
Prevention of Acute and recurrent stroke by anti-hypertensives: interaction with thrombolysis.	103
Zerebrale Enzymatische Aktivitatin Verbindung mit Energieumwandlungsprozessen	98
Effetti degli anti-ipertensivi sulla prevenzione dell’ictus ischemico acuto e interazioni con la terapia trombolitica	90
Effects of Neuroprotectants Before and After Stroke: Statins and Anti-hypertensives	89
Prevention of acute and recurrent stroke with statins and interaction with thrombolysis	88
Neuroprotection for ischaemic stroke: current status and challenges	83
Pharmacological therapy of acute ischaemic stroke: Achievements and problems	82
Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives	62
Totale	1.184

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	38	0	0	0	0	0	0	0	5	0	1	8	24
2022/2023	183	18	13	6	3	16	14	0	15	90	0	5	3
2023/2024	76	8	18	2	4	5	19	5	7	0	3	5	0
2024/2025	175	6	12	2	9	2	8	6	14	51	5	24	36
2025/2026	394	33	24	57	50	60	16	62	17	39	26	3	7
2026/2027	85	5	16	13	29	22	0	0	0	0	0	0	0
Totale													1.184